Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science
Psychedelics’ return to the scientific and cultural spotlight—framed here by a new book on Margaret Mead, Cold War politics, and the suppression of LSD research—sparks wide-ranging debate over their promise and perils. Commenters weigh emerging medical uses (from PTSD and addiction treatment to couples therapy) against risks like psychosis, cardiac effects, addiction in the case of MDMA, and naïve techno-utopianism about “drugs that fix everything.” Many call for rigorous, controlled research and regulated access, while disagreeing sharply over whether psychedelics genuinely transform moral outlooks or simply attract romanticized, quasi-religious narratives.
Meta / Post Context
- Thread notes that the book’s author is a familiar community historian and that the post surfaced via a site-curated-pick mechanic, not pinning.
- One commenter mentions the author briefly offering an AMA in the thread and another says they pre‑ordered the book.
Pharmacology, Mechanisms, and Safety
- Strong interest in next‑generation psychedelics with:
- Reduced 5‑HT2B activation due to concerns about heart valve pathology, especially with frequent/microdosing.
- Less 5‑HT3 activation to reduce nausea.
- Debate over “non‑hallucinogenic 5‑HT2A agonists”: some call it unrealistic given how these drugs raise “brain entropy,” others point to active research into psilocybin‑like, non‑hallucinogenic candidates.
- Discussion of anti‑nausea strategies: ondansetron and ginger (both 5‑HT3 related), CBD as a more complex case with potential serotonin‑syndrome concerns and CYP interactions.
Therapeutic Value vs. Limitations
- Many report profound positive personal effects: perspective shifts on anger, hate, racism/xenophobia, and life direction; MDMA praised for relationship/couples work; single psychedelic experiences described as life‑reframing.
- Others find effects mostly recreational or mild, or see no grand “insight,” leading to skepticism about hype and “psychedelics solve everything” narratives.
- Some argue these substances can help with addiction and confronting death, if used in careful therapeutic contexts.
Risks, Adverse Outcomes, and Set/Setting
- Examples of harm: triggering schizophrenia, a suicide following LSD (user believes closely related), historical LSD treatment of psychopaths apparently worsening recidivism, risk of psychosis and dangerous behavior.
- Emphasis that set and setting matter greatly; psychedelics can be used for both “liberation” and coercive/mind‑control contexts.
- Concerns that a consumerist “pill will fix me” mindset and uncontrolled environments lead to bad trips or trauma resurfacing.
Policy, Regulation, and Research Culture
- Some see the war on drugs as a wrongful shutdown of promising research; others warn against repeating earlier utopian overreach.
- Tension between:
- Calls for tightly controlled, therapeutic usage due to psychosis and public‑safety risks.
- Libertarian arguments for safe, known‑quality supply and personal choice.
- Comparisons with alcohol, weed, SSRIs, and TikTok:
- Some feel psychedelics are held to a higher standard than widely used but harmful or poorly understood substances.
- Others note SSRIs at least went through formal trials (though their effect size vs placebo is questioned), and point to emerging psilocybin/ketamine data.
Psychedelics, Creativity, and Tech History
- Anecdotes link LSD to breakthroughs in networking protocol design and improvisational music.
- One early technologist reportedly opposed drug testing because major technical insights came while on LSD.
Culture, Religion, and Attitudes
- Several note an almost religious or mystical tone among both users and some researchers, which some find inspiring and others find off‑putting or cult‑like.
- Debate over whether psychedelics are “great for” dismantling racism/xenophobia:
- Supporters cite direct experiences of radical attitude shifts.
- Skeptics demand stronger evidence than anecdotes and worry about grandiose claims.